Nicht lieferbar
rhErythropoietin in Cancer Supportive Treatment
Versandkostenfrei!
Nicht lieferbar
Table of contents:The significance of anaemia in cancer patients: progress in understanding haematopoiesis; pathophysiology of cancer-related anaemia; the incidence and clinical significance of anaemia in malignant diseases; the cost-effectiveness of rhEPO use in anaemia of cancer; problems of blood transfusion specific to cancer patients: problems of providing a national blood-transfusion service; the effect of blood donation on prognosis and infectious complications after colorectal cancer surgery;This work assesses the significance of anaemia in malignant disease and examines the applicatio...
Table of contents:
The significance of anaemia in cancer patients: progress in understanding haematopoiesis; pathophysiology of cancer-related anaemia; the incidence and clinical significance of anaemia in malignant diseases; the cost-effectiveness of rhEPO use in anaemia of cancer; problems of blood transfusion specific to cancer patients: problems of providing a national blood-transfusion service; the effect of blood donation on prognosis and infectious complications after colorectal cancer surgery;
This work assesses the significance of anaemia in malignant disease and examines the application of modern molecular biology in cancer therapy. It presents the proceedings of an international workshop, summarizing the development and clinical trials of erythropoietin, and demonstrating its efficacy in maintaining haemoglobin levels or prevanting anaemia due to erythropoietin deficiency. The use of blood transfusion in cancer treatment, and the problems facing blood transfusion services since increased awareness of HIV, are discussed.
The significance of anaemia in cancer patients: progress in understanding haematopoiesis; pathophysiology of cancer-related anaemia; the incidence and clinical significance of anaemia in malignant diseases; the cost-effectiveness of rhEPO use in anaemia of cancer; problems of blood transfusion specific to cancer patients: problems of providing a national blood-transfusion service; the effect of blood donation on prognosis and infectious complications after colorectal cancer surgery;
This work assesses the significance of anaemia in malignant disease and examines the application of modern molecular biology in cancer therapy. It presents the proceedings of an international workshop, summarizing the development and clinical trials of erythropoietin, and demonstrating its efficacy in maintaining haemoglobin levels or prevanting anaemia due to erythropoietin deficiency. The use of blood transfusion in cancer treatment, and the problems facing blood transfusion services since increased awareness of HIV, are discussed.